Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02858505Phase 2Completed
Phase 2, randomised trial of ferrous bisglycinate in iron deficiency anemia (IDA) (2 arms), sponsored by Assiut University. Primary endpoint: Hemoglobin level at 24 weeks. Started Aug 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02858505.